Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 4
2021 1
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Stage IIIC2 Cervical Cancer FIGO 2018"
Page 1
Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
Qin F, Pang H, Yu T, Luo Y, Dong Y. Qin F, et al. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221086403. doi: 10.1177/15330338221086403. Technol Cancer Res Treat. 2022. PMID: 35341413 Free PMC article. Review.
The presence of lymph node metastasis (LNM) is an independent prognostic factor for progression-free survival (PFS) and overall survival (OS) in cervical cancer patients. ...The purpose of this review is to summarize the choice of treatment for stage I …
The presence of lymph node metastasis (LNM) is an independent prognostic factor for progression-free survival (PFS) and overall survi …
FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A, Chopra S, Mittal P, Patil G, Mahantshetty U, Gurram L, Swamidas J, Ghosh J, Gulia S, Popat P, Deodhar K, Maheshwari A, Gupta S. Raut A, et al. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1248-1256. doi: 10.1016/j.ijrobp.2020.07.020. Epub 2020 Jul 15. Int J Radiat Oncol Biol Phys. 2020. PMID: 32681859
PURPOSE: In 2018, the International Federation of Gynecology and Obstetrics (FIGO) proposed a new staging for cervical cancer. The present study was designed to reclassify patients with locally advanced cervix cancer and perform a comparative ev …
PURPOSE: In 2018, the International Federation of Gynecology and Obstetrics (FIGO) proposed a new staging for cervical
The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK. McComas KN, et al. Gynecol Oncol. 2020 Jan;156(1):85-92. doi: 10.1016/j.ygyno.2019.10.025. Epub 2019 Nov 16. Gynecol Oncol. 2020. PMID: 31744640
OBJECTIVE: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer changed from a clinical system to a clinical/pathologic/radiologic system with stages IIIC1 and IIIC2 indicating positive …
OBJECTIVE: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer
Chemoradiotherapy in the treatment of cervical cancer - a single institution retrospective review.
Pechačová Z, Lohynská R, Weitoschová Z, Zikán M, Dubová O, Tomancová V, Kmoníčková E, Pála M, Drbohlavová T. Pechačová Z, et al. Klin Onkol. 2022 Spring;35(2):139-149. doi: 10.48095/ccko2022139. Klin Onkol. 2022. PMID: 35459339 English.
BACKGROUND: The aim of this study is a retrospective analysis of treatment outcomes and toxicity in a group of patients with cervical cancer who underwent (chemo) radiotherapy at the Institute of Radiation Oncology in Bulovka University Hospital in Prague in the per …
BACKGROUND: The aim of this study is a retrospective analysis of treatment outcomes and toxicity in a group of patients with cervical
Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
Zhang Y, Ding J, Hua K. Zhang Y, et al. J Int Med Res. 2022 Jan;50(1):3000605211067397. doi: 10.1177/03000605211067397. J Int Med Res. 2022. PMID: 34986672 Free PMC article.
METHODS: We re-staged 64 surgical IB-IIA (FIGO 2009) SCNEC patients according to the FIGO 2018 system and refined stage IIIC of FIGO 2018 based on tumor local invasion. ...CONCLUSIONS: For stage II SCNEC patients, FIGO 2009 underes …
METHODS: We re-staged 64 surgical IB-IIA (FIGO 2009) SCNEC patients according to the FIGO 2018 system and refined st
Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI, Hershman DL. Wright JD, et al. Obstet Gynecol. 2019 Jul;134(1):49-57. doi: 10.1097/AOG.0000000000003311. Obstet Gynecol. 2019. PMID: 31188324 Free PMC article.
OBJECTIVE: To examine the prognostic performance of the revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging schema. ...Using clinical and pathologic data, each patient's stage was classified u …
OBJECTIVE: To examine the prognostic performance of the revised 2018 International Federation of Gynecology and Obstetrics (FIGO
Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J, Cho Y, Kim N, Chung SY, Kim JW, Lee IJ, Kim YB. Kim J, et al. Gynecol Oncol. 2021 Mar;160(3):735-741. doi: 10.1016/j.ygyno.2020.12.012. Epub 2020 Dec 22. Gynecol Oncol. 2021. PMID: 33358037
Survival of stage IIIC cervix cancer depended on the local extent of the tumor: the 5-year PFS of T1, T2, and T3 stages were 80.3%, 73.9%, and 45.5% for IIIC1 and 100%, 44.9%, and 23.4% for IIIC2. ...CONCLUSIONS: FIGO 2018 revision was associate …
Survival of stage IIIC cervix cancer depended on the local extent of the tumor: the 5-year PFS of T1, T2, and T3 stages
Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
Wang R, Xiao Y, Ma L, Wu Z, Xia H. Wang R, et al. Gynecol Obstet Invest. 2022;87(6):398-405. doi: 10.1159/000527661. Epub 2022 Oct 21. Gynecol Obstet Invest. 2022. PMID: 36273460 Free PMC article.
A Cox proportional hazards model was used to estimate the independent prognostic factors. RESULTS: A number of 110 patients diagnosed as HG-NECC at the pathological stage IA2 to IIIC2 according to the International Federation of Gynecology and Obstetrics ( …
A Cox proportional hazards model was used to estimate the independent prognostic factors. RESULTS: A number of 110 patients diagnosed …
Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A, Aslan K, Bulut AN, Akilli H, Öz M, Haberal A, Meydanli MM. Ayhan A, et al. Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:209-214. doi: 10.1016/j.ejogrb.2019.07.002. Epub 2019 Jul 6. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31325847
OBJECTIVE: The purpose of this study was to compare the prognostic value of the revised FIGO staging system with that of the 2009 FIGO staging system for women previously staged as IB disease. ...CONCLUSION: When compared to the 2009 F
OBJECTIVE: The purpose of this study was to compare the prognostic value of the revised FIGO staging system with that o …
Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J, Srivastava A, Chundury A, Schwarz JK, Markovina S, Thaker PH, Massad LS, Mutch DG, Powell MA, Grigsby PW, Lin AJ. Contreras J, et al. Int J Gynecol Cancer. 2020 Aug;30(8):1157-1161. doi: 10.1136/ijgc-2020-001412. Epub 2020 Jun 11. Int J Gynecol Cancer. 2020. PMID: 32527770
The 2018 International Federation of Gynecology and Obstetrics (FIGO) clinical stages were IB1 (n=19), IB2 (n=7), IIB (n=7), IIIC1 (n=19), and IIIC2 (n=1). ...CONCLUSIONS: Post-operative IMRT with high dose rate brachytherapy for patients with cervical
The 2018 International Federation of Gynecology and Obstetrics (FIGO) clinical stages were IB1 (n=19), IB2 (n=7), IIB (n=7), I …
11 results